S Sardaana
← Back to Sardaana Health
Health News

Popular high-volume injections for Achilles tendon pain did no better than sham at one year, BMJ trial finds

In the Inject trial of 192 adults, high-volume injections with or without a steroid did not improve pain and disability versus a sham at 12 months; the steroid version gave a small early benefit but worse results at 26 weeks.

High-volume injections — about 50 mL of saline plus local anaesthetic, often with a corticosteroid, delivered next to the Achilles tendon — are increasingly used worldwide for stubborn midportion Achilles tendinopathy. The randomised Inject trial, published in The BMJ on 28 October 2026, tested whether they work over a full year.

The study

  • Design: single-centre (Melbourne, Australia), participant- and assessor-masked, three-arm randomised controlled trial with an economic evaluation.
  • Participants: 192 adults (mean age 48.7; median symptom duration two years) who had not responded to prior treatment, randomised to sham (small anaesthetic injection placed away from the target), high-volume injection without steroid, or high-volume injection with 25 mg hydrocortisone. Everyone received the same exercise programme and advice.
  • Primary outcome: pain and disability on the VISA-A scale (0–100) at 52 weeks; 94% provided data.

Results

  • At 12 months, neither injection beat sham: with steroid −3.5 points (98.33% CI −12.0 to 5.0), without steroid +4.0 (−4.2 to 12.3).
  • The steroid injection gave a small benefit at six weeks (+9.2 vs sham, below the 10-point target) but worse outcomes than the steroid-free injection at 26 weeks (−8.6).
  • In the economic analysis the steroid injection was cheaper than sham with similar quality-adjusted life years, largely through less time off work early on; the authors urge caution because the health gain was negligible.
  • No tendon ruptures and no serious trial-related adverse events.

The authors conclude the clinical data “do not support routine use” of high-volume steroid injections for this condition.

Limitations

Single centre with participants mainly recruited via social media, so they may differ from hospital patients; the injecting radiologist and nurse could not be masked; only one of four recommended core outcome instruments was used; economic data had growing gaps; and with many outcomes and time points some differences may be due to chance. Discuss treatment options with your doctor or physiotherapist.

Also available in: Саха тылаРусскийEspañol中文Portuguêsالعربية

Sign in to Sardaana

An account is only needed to publish, reply, vote and collaborate.

You can browse the site and read news, projects and the forum without registering.